The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To assess the risk of venous thromboembolism in women using hormone replacement therapy by study design, characteristics of the therapy and venous thromboembolism, and clinical background. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline. STUDIES REVIEWED: Eight observational studies and nine randomised controlled trials. INCLUSION CRITERIA: Studies on hormone replacement therapy that reported venous thromboembolism. REVIEW MEASURES: Homogeneity between studies was analysed using chi(2) and I(2) statistics. Overall risk of venous thromboembolism was assessed from a fixed effects or random effects model. RESULTS: Meta-analysis of observational studies showed that oral oestrogen but not transdermal oestrogen increased the risk of venous thromboembolism. Compared with non-users of oestrogen, the odds ratio of first time venous thromboembolism in current users of oral oestrogen was 2.5 (95% confidence interval 1.9 to 3.4) and in current users of transdermal oestrogen was 1.2 (0.9 to 1.7). Past users of oral oestrogen had a similar risk of venous thromboembolism to never users. The risk of venous thromboembolism in women using oral oestrogen was higher in the first year of treatment (4.0, 2.9 to 5.7) compared with treatment for more than one year (2.1, 1.3 to 3.8; P<0.05). No noticeable difference in the risk of venous thromboembolism was observed between unopposed oral oestrogen (2.2, 1.6 to 3.0) and opposed oral oestrogen (2.6, 2.0 to 3.2). Results from nine randomised controlled trials confirmed the increased risk of venous thromboembolism among women using oral oestrogen (2.1, 1.4 to 3.1). The combination of oral oestrogen and thrombogenic mutations or obesity further enhanced the risk of venous thromboembolism, whereas transdermal oestrogen did not seem to confer additional risk in women at high risk of venous thromboembolism. CONCLUSION: Oral oestrogen increases the risk of venous thromboembolism, especially during the first year of treatment. Transdermal oestrogen may be safer with respect to thrombotic risk. More data are required to investigate differences in risk across the wide variety of hormone regimens, especially the different types of progestogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increasing risk of VTE with duration of estrogen use is in contrast with menopausal hormonal therapy, where the risk is highest in the first year of use and decreases with time. [122]”
From Estrogen and thrombosis: a bench to bedside review (2020) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Research works printed but not linked: 2
- Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
- Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.
Cited by
Sorted by citations
Items 301–400 of 567
Glueck, C. J., Goldenberg, N., & Wang, P. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000637 · Cited by 9
Endocrine Care of Transgender Adults
Fishman, S. L., Paliou, M., Poretsky, L., & Hembree, W. C. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-05683-4_8 · Cited by 9
Stanczyk, F. Z., & Bhavnani, B. R. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.08.013 · Cited by 8
A current perspective into young female sex hormone replacement: a review
Giordano Imbroll, M., & Gruppetta, M. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1816820 · Cited by 7
Khalifey, H. T., Mahereen, R., Adwan, R., Chahine, R., Kaidali, M., Mirza, S. F., Tullah, S. N., Shaikh, S., Hammad, S., & Sukkarieh, H. H. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1745210 · Cited by 7
Oestrogen-based therapies for menopausal symptoms
Laing, A., & Hillard, T. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101789 · Cited by 7
Yuk, J., Kim, G. S., Byun, Y. S., Yang, S., Kim, M., Yoon, S., Seo, Y. S., & Kim, B. G. (2024) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17803 · Cited by 7
10 Jahre Women's Health Initiative (WHI): Was haben wir gelernt?
Birkhäuser, M., Hadji, P., & Imthurn, B. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH) · doi:10.5167/uzh-90738 · Cited by 6
Effects of sympatholytic therapy on postmenopausal symptoms in hypertensive postmenopausal women
Kujala, S. M., Pöyhönen‐Alho, M., & Kaaja, R. (2013) · Climacteric · doi:10.3109/13697137.2013.842226 · Cited by 7
Is there a time limit for systemic menopausal hormone therapy?
Lipold, L. D., Batur, P., & Kagan, R. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.15161 · Cited by 7
Nelson, L. M., Spencer, H., Hijane, K., Thinuan, P., Nelson, C. W., Vincent, A. J., Gordon, C. M., Plant, T. M., & Fazeli, P. K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1227253 · Cited by 9
Low-Dose Estradiol Spray: a Novel Treatment for Vasomotor Instability in Postmenopausal Women
Buster, J. E. (2009) · Women s Health · doi:10.2217/17455057.5.1.23 · Cited by 7
Szabó, A., Hartmann, P., Varga, R., Jánvári, K., Lendvai, Z., Szalai, I., Gomez, I., Varga, G., Greksa, F., Németh, I., et al. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.11.004 · Cited by 7
Panay, N., Hamoda, H., Arya, R., & Savvas, M. (2013) · Cited by 7
Featured paper Menopausal hormone therapy and venous thromboembolism
Bińkowska, M. (2014) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2014.46468 · Cited by 7
Oestrogen therapy: Oralversusnon-oral administration
von Schoultz, B. (2009) · Gynecological Endocrinology · doi:10.1080/09513590902836551 · Cited by 7
Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy
Sterling, J. A. (2007) · Hospital Pharmacy · doi:10.1310/hpj4206-578 · Cited by 7
Menopause hormone therapy, migraines, and thromboembolism
Khandelwal, S., Meeta, M., & Tanvir, T. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.11.011 · Cited by 6
Low thrombin generation in postmenopausal women using estetrol
Morimont, L., Didembourg, M., Bouvy, C., Jost, M., Taziaux, M., Oligschlaeger, Y., van Rooijen, M. A., Gaspard, U., Foidart, J., & Douxfils, J. (2024) · Climacteric · doi:10.1080/13697137.2023.2292066 · Cited by 6
Criteria for the choice and monitoring of Menopausal Hormone Therapy
Ruan, X., & Mueck, A. O. (2024) · Current Medicine · doi:10.1007/s44194-024-00038-5 · Cited by 6
Role of thrombophilia testing: con
Stevens, S. M. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1170-1 · Cited by 6
Hansen, K. A., & Eyster, K. M. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31825cab41 · Cited by 6
Effets membranaires du récepteur alpha des œstrogènes
Adlanmérini, M., Fabre, A., Boudou, F., Riant, É., Fontaine, C., Laurell, H., Gourdy, P., Lenfant, F., & Arnal, J. (2015) · médecine/sciences · doi:10.1051/medsci/20153112011 · Cited by 6
Pubertal induction in girls with Turner Syndrome
Aversa, T., Corica, D., Pepe, G., PAJNO, G. B., Valenzise, M., MESSINA, M. F., & WASNIEWSKA, M. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03285-x · Cited by 6
Pérez-López, F. R., Cuadros, J. L., Fernández‐Alonso, A. M., Cuadros, Á. M., Sabatel, R., & Chedraui, P. A. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903367028 · Cited by 6
Saul, S. R., & KASE, N. G. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13952 · Cited by 6
Franz, K., Markó, L., Mähler, A., Chakaroun, R., Heinitz, S., Schlögl, H., Sacher, J., Steckhan, N., Dechend, R., Adams, N., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087982 · Cited by 5
Tromeur, C., Mao, R. L., Leven, C., Couturaud, F., Thereaux, J., & Lacut, K. (2020) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2020.02.014 · Cited by 5
Therapy with climara in surgical menopause.
Badoi, D., Crauciuc, E., Rusu, L., & Luca, V. (2012) · The Medical-Surgical Journal · Cited by 5
Estradiol gel 0.1% relieves vasomotor symptoms independent of age, ovarian status, or uterine status
Hedrick, R. E., Ackerman, R. T., Koltun, W. D., & Halvorsen, M. B. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e04b75 · Cited by 5
Use of Hormone Therapy in Women with Early Menopause and Premature Ovarian Insufficiency
Lersten, I. L., Clain, E., & Santoro, N. F. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1721719 · Cited by 6
Hormone replacement therapy: update and practical prescribing
Noble, N. (2020) · Journal of Prescribing Practice · doi:10.12968/jprp.2020.2.2.91 · Cited by 5
Løbo, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00015-9 · Cited by 5
Transdermales Östradiol und Progesteron
Mueck, A. O. (2017) · Gynäkologische Endokrinologie · doi:10.1007/s10304-016-0109-8 · Cited by 5
Premature ovarian insufficiency: a syndrome or diagnosis
Татарчук, Т. Ф., Косей, Н. В., & Tutchenko, T. М. (2017) · Reproductive Endocrinology · doi:10.18370/2309-4117.2017.34.16-22 · Cited by 5
Anderson, J. A. M., Hogg, K. E., & Weitz, J. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00140-2 · Cited by 5
Laboratory Investigation of Thrombophilia / LABORATORIJSKO ISPITIVANJE TROMBOFILIJA
Margetić, S. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2013-0041 · Cited by 6
Type of hormone replacement therapy and risk of venous thromboembolism
Roberts, H. (2008) · BMJ · doi:10.1136/bmj.39556.666944.80 · Cited by 5
Cushman, M. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.199083 · Cited by 5
Glynne, S., Kamal, A., Neville, A. M., McColl, L., Naji, O., Newson, L. R., & Reisel, D. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-08161-w · Cited by 4
Tailoring transdermal estradiol dose to maximize benefits and minimize risks
Glynne, S., & Simon, J. A. (2026) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002723 · Cited by 4
Risk factors, management and consequences of severe menopausal vasomotor symptoms
Hickey, M., Huguenin, A., Chung, H., & Mishra, G. D. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01245-w · Cited by 4
Diretriz Brasileira sobre a Saúde Cardiovascular no Climatério e na Menopausa – 2024
de Oliveira, G. M. M., de Almeida, M. C. C., Artucio, C., Espíndola, L. N., Rivera, M. A. M., Filho, A. L. D. S., Marques-Santos, C., Fernandes, C. E., Albuquerque, C. J. D. M., Freire, C. M. V., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240478 · Cited by 24
Emerging Facade of Menopausal Hormone Therapy
REES, M. C. P. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0030-1262894 · Cited by 4
Thrombosis risk with estrogen use for puberty induction in congenital disorders of glycosylation
Eklund, E. A., Miller, B. S., & Boucher, A. A. (2023) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2023.107562 · Cited by 4
Bhamra, R. K., Margolis, M. B., LIU, J. H., Hendy, C. H., Jenkins, R. G., & DiLiberti, C. E. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181f7a2d6 · Cited by 4
Pharmacology of Hormone Replacement Therapy in Menopause
Voican, A., Francou, B., Novac, L. V., Chabbert‐Buffet, N., Canonico, M., Méduri, G., Lombès, M., Scarabin, P., Young, J., Guiochon‐Mantel, A., et al. (2012) · InTech eBooks · doi:10.5772/32655 · Cited by 4
Self-citationPrevention and Treatment of Hormone-Associated Venous Thromboembolism: A Patient Management Approach
Ueng, J., & Douketis, J. D. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.05.008 · Cited by 4
Menopause care for obese and diabetic women.
Verhaeghe, J. (2009) · PubMed Central · Cited by 4
Menopause and Care of the Mature Woman
Lobo, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-06986-1.00014-7 · Cited by 4
Evaluation of the isoflavones and estrogen effects on the rat adrenal
Marinho, D. S., Calió, M. L., dos Santos, M. A., Ko, G. M., Teixeira, C. P., Carbonel, A. A. F., Lisbôa-Nascimento, T., Castro, R. A., Simões, R. S., & Bertoncini, C. R. A. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1318371 · Cited by 4
Managing common problems in the menopause
Newson, L. R., & Panay, N. (2018) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738018769925 · Cited by 4
López, M. V., Soto-Becerra, P., Choque, R. C., Al‐kassab‐Córdova, A., Bernuy-Barrera, F., Palomino, H., Rojas, P., Vera, C., Lugo‐Martínez, G., & Mezones‐Holguín, E. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1960965 · Cited by 4
Smart Talk on Supplements and Botanicals
Dog, T. L. (2009) · Alternative and Complementary Therapies · doi:10.1089/act.2009.15106 · Cited by 4
Hormone replacement therapy and thrombotic risk: beauty is only skin deep
Rosendaal, F. R. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1346 · Cited by 4
Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms
Canonico, M., & Scarabin, P. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31822d6677 · Cited by 4
Self-citationKim, J., Bhupathiraju, S. N., Harrington, L. B., Hagan, K. A., Lindström, S., Manson, J. E., Kraft, P. L., & Kabrhel, C. (2022) · PubMed · doi:10.1097/gme.0000000000001924 · Cited by 3
Brazilian Guideline on Menopausal Cardiovascular Health – 2024
de Oliveira, G. M. M., de Almeida, M. C. C., Artucio, C., Espíndola, L. N., Rivera, M. A. M., Filho, A. L. D. S., Marques-Santos, C., Fernandes, C. E., Albuquerque, C. J. D. M., Freire, C. M. V., et al. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024rbgo100 · Cited by 7
Schachter, H., Blaszczak, J., & Barnes, G. D. (2025) · Vascular Medicine · doi:10.1177/1358863x251334141 · Cited by 4
Endocrinology, Hormone Replacement Therapy (HRT), and Aging
Houlberg, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-95031-0_2 · Cited by 3
Hormone Therapy and Replacement in Cancer and Aging-related Diseases
Rangel, L. B. A., Kirubamani, H., Silva, I. V., & Junior, P. C. M. L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77810 · Cited by 3
Ménopause et risque thromboembolique veineux. RPC Les femmes ménopausées du CNGOF et du GEMVi
Hugon‐Rodin, J., Pérol, S., & Plu‐Bureau, G. (2021) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2021.03.018 · Cited by 3
Self-citationMittal, M., Chitongo, P., Supramaniam, P. R., Cardozo, L., Savvas, M., Panay, N., Arya, R., & Hamoda, H. (2022) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001944 · Cited by 3
López, M. V., Soto-Becerra, P., Chedraui, P. A., Manyari, J. D. O., Al‐kassab‐Córdova, A., Manyari, Á. A. O., Fernandez-Sosaya, J., Moya-Silvestre, E., Rojas, P., Lugo‐Martínez, G., et al. (2023) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002268 · Cited by 3
Lanzi, V., Indirli, R., Tripodi, A., Clerici, M., Bonomi, M., Cangiano, B., Petria, I., Arosio, M., Mantovani, G., & Ferrante, E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae317 · Cited by 5
Quality indicators for endometrial cancer care in Japan
Kakuwa, T., Ichinose, Y., Rikitake, R., Ishii, T., Nagase, S., Kobayashi, Y., Kaneuchi, M., Tokunaga, H., Seino, M., Kajiyama, H., et al. (2025) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2025.36.e77 · Cited by 3
Desplantie, O., & Ramanathan, K. (2016) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000443 · Cited by 3
Saavedra, C. (2020) · Infectio · doi:10.22354/in.v24i3.894 · Cited by 3
Le traitement hormonal de la ménopause : aspects pratiques
Sonigo, C., Dray, G., & Chabbert‐Buffet, N. (2012) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2012.09.002 · Cited by 3
Angelillo‐Scherrer, A., & Nagler, M. (2016) · Therapeutische Umschau · doi:10.1024/0040-5930/a000843 · Cited by 3
Matsui, S., Yasui, T., Kasai, K., Keyama, K., Yoshida, K., Kato, T., Uemura, H., Kuwahara, A., Matsuzaki, T., & Irahara, M. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1285275 · Cited by 3
Herbal medicines for menopausal symptoms
(2009) · Evidence-Based Nursing · doi:10.1136/dtb.2008.12.0031 · Cited by 3
Informing Women About Hormone Replacement Therapy
Mosconi, P., Donati, S., Colombo, C., Mele, A., Liberati, A., & Satolli, R. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e3181b282c2 · Cited by 3
Artificial intelligence in primary ovarian insufficiency management: opportunities and challenges
Zhou, R., Wei, Y., Xiong, Y., Su, B., Xie, J., Hu, L., & Lei, X. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03660-w · Cited by 2
Hugueny, J., de Ricolfis, A., Johnson, N., Chabbert‐Buffet, N., & Cristofari, S. (2025) · Thrombosis Research · doi:10.1016/j.thromres.2025.109516 · Cited by 2
Acute and Chronic Pulmonary Embolism: Perspectives on Diagnosis and Management
Unterman, A., & Kramer, M. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812615-8.00024-7 · Cited by 2
Actividades preventivas en la mujer. Actualización PAPPS 2022
García‐Franco, A. L., Fernández, J. A. B., Piñeiro, M. J. I., Alonso‐Coello, P., Cabello, C. R., Iglesias, A. P., & Goñi, J. L. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102471 · Cited by 2
Sundell, M. (2023) · Linköping University medical dissertations · doi:10.3384/9789180751216 · Cited by 2
Hasser, E., Brody, J. A., Bartz, T. M., Thibord, F., Li‐Gao, R., Kauko, A., Wiggins, K. L., Teder‐Laving, M., Kim, J., Munsch, G., et al. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.05.011 · Cited by 2
Kampo medicine in the management of menopausal symptoms: A narrative review of therapeutic potential
Liu, Y., Kobayashi, S. S., Wang, L., Ren, Y.-M., & Song, P. (2025) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2025.01039 · Cited by 2
Mansencal, D., Mansencal, N., Miliani, K., Toussaint, A., Pépin, M., Beauchet, A., Prati, G., de Chazournes, P. B., Lévesque, T., Weizman, O., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf460 · Cited by 3
Contraception and Hormonal Therapy in Women with Diabetes Mellitus
Durand-Carbajal, M. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000554 · Cited by 1
Herz-Kreislauf-Risiko und Hormontherapie in der Postmenopause
Windler, E. E. T., Mueck, A. O., Zyriax, B., & Ortmann, O. (2010) · Der Gynäkologe · doi:10.1007/s00129-009-2467-y · Cited by 2
Association of ischemic stroke, hormone therapy, and right to left shunt in postmenopausal women
Greep, N. C., Liebeskind, D. S., Gevorgyan, R., Truong, T., Cua, B., Tseng, C., Dodick, D. W., Demaerschalk, B. M., Thaler, D. E., & Tobis, J. M. (2014) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25431 · Cited by 2
Medical history screening for thrombophilic risk: is this adequate?
Eggert-Kruse, W., Ziegler, A., Horlbeck, S., & Strowitzki, T. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.02.053 · Cited by 2
Should hormone replacement therapy be used in postmenopausal women for voiding dysfunction?
Stothers, L. S. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.1049 · Cited by 2
Arterial stiffness in czech population measured by Vasera1500
Dobšák, P., Sosíková, M., Dušek, L., Souček, M., Novàkovâ, M., Yambe, T., Wolf, J., Vítovec, J., Špinarová, L., Soška, V., et al. (2010) · Cited by 2
Taradaj, J., Halski, T., Ozon, M., Rajfur, J. B., Pasternok, M., Kwaśna, K., Chmielewska, D. D., Piecha, M., & Skrzypulec‐Plinta, V. (2013) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2013.39811 · Cited by 2
Should HRT be duration limited?
Pitkin, J. (2013) · Menopause international · doi:10.1177/1754045313507176 · Cited by 2
Reproductive and Hormonal Issues in Women with Autoimmune Diseases
Chakravarty, E. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00038-8 · Cited by 2
Morris, T. A., & Fedullo, P. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00057-9 · Cited by 2
Trujillo, C. H. S. (2020) · Infectio · doi:10.22354/in.v24i3.895 · Cited by 2
Is It Possible to Manage the Symptoms of the Menopause Without Estrogen?
Simpson, P. D., & Morris, E. P. (2015) · Women s Health · doi:10.2217/whe.15.23 · Cited by 2
Lung cancer and hormone replacement therapy
Canonico, M., Plu‐Bureau, G., & Scarabin, P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60039-6 · Cited by 2
Self-citationKaniecki, R. G., Taylor, F. R., & Landy, S. H. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01836.x · Cited by 2
BMJ Publishing Group Ltd (2009) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2009.03.0011 · Cited by 2
The ovarian immune pathology and reproductive failures
Wu, L., Fang, X., Wang, Y., & Kwak-Kim, J. Y.-H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90805-4.00018-3 · Cited by 1
Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment. A review
Fedyanin, M. Y., Rumyantsev, А. А., & Tryakin, A. A. (2024) · Journal of Modern Oncology · doi:10.26442/18151434.2024.1.202618 · Cited by 1
Premature ovarian insufficiency
Sayed, H. A., & Jayaprakasan, K. (2024) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12943 · Cited by 1
Ramadan, S., Okda, M., Kansal, D., & Thompson, B. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.09.009 · Cited by 1
Metadata
- Authors
- Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y.
- Affiliations
- Université Paris-Sud (FR)
- Glasgow Royal Infirmary (GB)
- Corresponding author
- Canonico, Marianne
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2008-05-20
- Volume
- 336
- Issue
- 7655
- Pages
- 1227-1231
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC2405857
- OpenAlex
- W2008660261
- Cited by
- 569
- References
- 73
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 20 · 2023: 17 · 2022: 29 · 2021: 30 · 2020: 21 · 2019: 29 · 2018: 27 · 2017: 26 · 2016: 30 · 2015: 28 · 2014: 32 · 2013: 45 · 2012: 35
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
- Keywords
- hormone replacement therapy, venous thromboembolism, postmenopausal women, oral estrogen, transdermal estrogen, obesity, unopposed estrogen, progestogens, thrombosis risk, treatment duration
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Female, Humans, Risk, Risk Factors, Estrogen Replacement Therapy, Randomized Controlled Trials as Topic, Postmenopause, Venous Thromboembolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
